BIT
CSCI

BlackRock Institutional Trust’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

BlackRock Institutional Trust’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5
Closed -$57K – 4047
2014
Q1 		$57K Sell
5
-5
-50% -$64.5K ﹤0.01% 3810
2013
Q4 		$145K Hold
10
– – ﹤0.01% 3762
2013
Q3 		$153K Buy
10
+3
+43% +$47.7K ﹤0.01% 3718
2013
Q2 		$139K Buy
+7
New +$133K ﹤0.01% 3693

Other funds holding CSCI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $989M AUM 27.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's CSCI Position: Q2 2014 in Review

BlackRock Institutional Trust sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2014, closing a stake of 5 shares — an estimated $57K sold.

BlackRock Institutional Trust first reported a position in CSCI in Q2 2013 and held it in 4 quarters. The position peaked at $153K in Q3 2013. 14 funds tracked by Wall St. Rank hold CSCI as of Q2 2014.

  • BlackRock Institutional Trust reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 5 COSCIENS Biopharma Inc. Common Stock shares in Q2 2014, an estimated $57K.
  • BlackRock Institutional Trust first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2013 and held it in 4 quarters.
  • BlackRock Institutional Trust's COSCIENS Biopharma Inc. Common Stock position peaked at $153K in Q3 2013.
  • 14 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2014.

Based on BlackRock Institutional Trust's 13F filing for Q2 2014, filed 6 Aug 2014.